Spiegelman Daniel K
CIK 0001238403
Director
Filings
15
Latest May 26, 2026
Issuers covered
5
Showing
15 of 15
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 25% | -5.9% | -6.5% | +0.9% | -11.6% |
| 90 days | 4 | 25% | -9.0% | -18.5% | +23.8% | -22.9% |
| 180 days | 4 | 75% | +15.4% | +21.6% | +25.3% | -6.9% |
| 365 days | 4 | 75% | +34.7% | +40.5% | +78.2% | -20.5% |
Issuers
Companies where Spiegelman Daniel K has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SPRB | Spruce Biosciences, Inc. | 6 | May 26, 2026 |
| MYGN | Myriad Genetics Inc | 5 | Jun 7, 2024 |
| VTVT | Vtv Therapeutics Inc. | 2 | Jun 12, 2025 |
| KYTX | Kyverna Therapeutics, Inc. | 1 | Jun 2, 2025 |
| MAZE | Maze Therapeutics, Inc. | 1 | Sep 24, 2025 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|